July 7, 2026 · Form 4 insider transaction
Rhodes Jason P sold 5,000 shares of Dyne Therapeutics, Inc. at $23.61 per share, a transaction worth $118.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $23.50 to $23.794 inclusive.; The shares are held directly by AVA XI LP. AVA XI LLC is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of the securities held by AVA XI LP, except to the extent of his pecuniary interest therein, if any.